1. Home
  2. STOK vs PUMP Comparison

STOK vs PUMP Comparison

Compare STOK & PUMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • PUMP
  • Stock Information
  • Founded
  • STOK 2014
  • PUMP 2007
  • Country
  • STOK United States
  • PUMP United States
  • Employees
  • STOK N/A
  • PUMP N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • PUMP Oilfield Services/Equipment
  • Sector
  • STOK Health Care
  • PUMP Energy
  • Exchange
  • STOK Nasdaq
  • PUMP Nasdaq
  • Market Cap
  • STOK 517.0M
  • PUMP 550.9M
  • IPO Year
  • STOK 2019
  • PUMP 2017
  • Fundamental
  • Price
  • STOK $11.58
  • PUMP $6.55
  • Analyst Decision
  • STOK Strong Buy
  • PUMP Buy
  • Analyst Count
  • STOK 5
  • PUMP 5
  • Target Price
  • STOK $24.50
  • PUMP $9.75
  • AVG Volume (30 Days)
  • STOK 534.4K
  • PUMP 1.6M
  • Earning Date
  • STOK 08-06-2025
  • PUMP 07-30-2025
  • Dividend Yield
  • STOK N/A
  • PUMP N/A
  • EPS Growth
  • STOK N/A
  • PUMP N/A
  • EPS
  • STOK 0.88
  • PUMP N/A
  • Revenue
  • STOK $190,908,000.00
  • PUMP $1,397,859,000.00
  • Revenue This Year
  • STOK $378.84
  • PUMP N/A
  • Revenue Next Year
  • STOK N/A
  • PUMP $9.57
  • P/E Ratio
  • STOK $13.21
  • PUMP N/A
  • Revenue Growth
  • STOK 2333.81
  • PUMP N/A
  • 52 Week Low
  • STOK $5.35
  • PUMP $4.61
  • 52 Week High
  • STOK $16.15
  • PUMP $11.17
  • Technical
  • Relative Strength Index (RSI)
  • STOK 67.25
  • PUMP 62.13
  • Support Level
  • STOK $11.43
  • PUMP $6.28
  • Resistance Level
  • STOK $12.25
  • PUMP $6.89
  • Average True Range (ATR)
  • STOK 0.51
  • PUMP 0.31
  • MACD
  • STOK 0.02
  • PUMP 0.08
  • Stochastic Oscillator
  • STOK 75.90
  • PUMP 78.48

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About PUMP ProPetro Holding Corp.

ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.

Share on Social Networks: